
Neurotechnology development

Combining neuroscience, advanced engineering and manufacturing
Our capabilities drive the development of technologies and devices that can access and directly interface with the human brain. The aim is to either record brain signals for improved communication or movement control through intelligent prostheses and/or modulate the brain’s activity via electrical, optical or biological means for therapy.
Our development efforts depend on close collaborations with clinical and academic leaders in the field of neuroscience and neurosurgery and take place within the strict ethical and regulatory frameworks in Switzerland, the EU and the US.

Key focus areas in neurotechnology development
The Wyss Center’s development efforts begin at the idea generation stage and continue with prototype fabrication and on to product development and clinical validation.
We develop innovative medical grade technologies that interface with the nervous system such as brain-machine interfaces, neuromonitoring and neurostimulation devices to understand, repair or replace nervous system function. Leading indications include epilepsy, Parkinson’s disease, ALS, spinal cord injury and stroke.
Our work spans the following aspects of development:
Concept - Conceptualization of innovative technologies that interface with the nervous system
Feasibility studies - Readiness screening and technical, clinical and business feasibility assessments including business model development and reimbursement scenarios
Prototype development - Design and prototyping of hardware and software subsystems and their integration
Validation - Testing, analysis, modeling and optimization in the laboratory and the clinic
Quality assurance - Providing confidence that all quality requirements are fulfilled according to European and US standards, technical documentation generation and review
Regulatory strategy and submission - Development of regulatory strategies as a technology is developed, technical documentation generation and review according to applicable EU and US standards and regulations
Clinical trials - Clinical trials protocol design and submission, collaboration with clinical groups for first-in-human studies
Commercialization - Licensing of technologies developed at the Wyss Center to commercial entities for the benefit of humankind
Team

Updates
-
10.03.2023
New project: InnerVoice
A new Wyss Center - University of Geneva collaboration aims to decode imagined speech directly from the brain using novel implanted electrodes and new algorithms.
Technology -
21.11.2022
Brain-computer interfaces: New technology. More data. Improving lives.
Symposium: As the BCI community shifts its focus to clinical studies for patient benefit, join us to hear from researchers and companies working together at the forefront of BCI development discussing paths to translation and BCI home-use.
Wyss Center -
09.11.2022
Latest neural signals recorded with ABILITY brain-computer interface and new details of the system presented at Society for Neuroscience meeting
Wyss Center’s ABILITY system, designed to improve quality of life and independence for people with severe paralysis, demonstrates safety and efficacy in pre-clinical trials.
Technology
